Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 ...

US pharma major Bristol Myers Squibb has announced positive results from POETYK PsA-1 (IM011-054) and POETYK PsA-2 (IM011-055 ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza ...

USA-based clinical-stage biopharma Traws Pharma saw its shares leap more than 150% to $12.57 as it announced progress in the ...

USA-based immunology company RAPT Therapeutics has entered into an exclusive license agreement with Shanghai Jemincare ...

Cytokinetics (Nasdaq: CYTK) has sold Sanofi (Euronext: SAN) exclusive rights to develop and commercialize aficamten in China.

Shionogi to acquire full ownership of its joint ventures with Ping An subsidiaries, dissolving partnerships to refocus on ...

XBiotech halts rheumatology program after Phase II trial failure for rheumatoid arthritis, citing data irregularities and ...

AstraZeneca gains EU approval for Tagrisso to treat unresectable locally advanced NSCLC based on Phase III LAURA data showing ...

US pharma major Eli Lilly today announced the US Food and Drug Administration (FDA) approved Zepbound its (tirzepatide) as ...

Spanish plasma-based medicines maker Grifols has announced disappointing top-line data from its Phase III PRECIOSA clinical ...